KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Ionis Pharmaceuticals (IONS) over the last 15 years, with Q3 2025 value amounting to 0.22%.

  • Ionis Pharmaceuticals' Return on Invested Capital rose 5200.0% to 0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22%, marking a year-over-year increase of 5200.0%. This contributed to the annual value of 0.92% for FY2024, which is 1500.0% down from last year.
  • As of Q3 2025, Ionis Pharmaceuticals' Return on Invested Capital stood at 0.22%, which was up 5200.0% from 0.3% recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Return on Invested Capital ranged from a high of 0.02% in Q3 2022 and a low of 1.63% during Q3 2023
  • Its 5-year average for Return on Invested Capital is 0.69%, with a median of 0.74% in 2024.
  • In the last 5 years, Ionis Pharmaceuticals' Return on Invested Capital surged by 10100bps in 2022 and then plummeted by -16500bps in 2023.
  • Quarter analysis of 5 years shows Ionis Pharmaceuticals' Return on Invested Capital stood at 0.04% in 2021, then plummeted by -1586bps to 0.73% in 2022, then tumbled by -42bps to 1.04% in 2023, then skyrocketed by 30bps to 0.72% in 2024, then soared by 70bps to 0.22% in 2025.
  • Its Return on Invested Capital stands at 0.22% for Q3 2025, versus 0.3% for Q2 2025 and 0.88% for Q1 2025.